Organism: Homo sapiens
Gene: 40074_at
Selected probe(set): 201761_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 40074_at (201761_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):7.693573
Number of Samples:9 / 12

Experimental	Hep-G2
	Human primary cancer cell line derived from the liver of a patient with hepatocellular carcinoma. Synonyms:HEP-G2; Hep G2; HEP G2; HepG2; HEPG2 Cellosaurus code:
Control	HepaRG
	Immortalized cancer cell line derived from female patient with hepatocellular carcinoma. Cells can be induced to differentiate into hepatocyte-like cells by exposure to DMSO. Synonyms:Hepa-RG Cellosaurus code:

Relative Expression (log2-ratio):7.1824207
Number of Samples:8 / 12

Experimental	hepatocyte (ESC)
	Hepatocyte-like cells differentiated from embryonic stem cells (ESC)
Control	HepaRG
	Immortalized cancer cell line derived from female patient with hepatocellular carcinoma. Cells can be induced to differentiate into hepatocyte-like cells by exposure to DMSO. Synonyms:Hepa-RG Cellosaurus code:

Relative Expression (log2-ratio):4.8276787
Number of Samples:2 / 2

Experimental	T-cell activation study 4
	T-cell samples antiCD3 activated for 30hrs.
Control	normal resting T-cell sample
	T cells resting for 30h.

Relative Expression (log2-ratio):4.7212973
Number of Samples:5 / 2

Experimental	glioma study 27 (astrocytoma, NOS)
	Primary tumor samples from resected brain tissues of patients with astrocytoma, NOS (WHO grade II astrocytoma).
Control	glioma study 27 (pilocytic astrocytoma)
	Primary tumor samples from resected brain tissues of patients with pilocytic astrocytoma (WHO grade I astrocytoma).

Relative Expression (log2-ratio):4.092107
Number of Samples:12 / 6

Experimental	retina pigment epithelium study 2 (fetal)
	Human cultured fetal retina pigment epithelium samples obtained at gestation age between week 16-18.
Control	retina pigment epithelium study 1 (fetal)
	Human native fetal retina pigment epithelium samples obtained at gestation age between week 16-18.

Relative Expression (log2-ratio):3.9308128
Number of Samples:2 / 2

Experimental	T-cell activation study 1
	CD4+ T-cell samples derived from PBMC´s of HIV-seronegative donors were activated with plate bound CD3 (1ug/ml) and soluble CD28 (50ng/ml) for 1 day.
Control	quiescent CD4+ T-cell sample
	Quiescent CD4+ T-cell samples derived from PBMC´s of HIV-seronegative donors.

Relative Expression (log2-ratio):3.871069
Number of Samples:3 / 2

Experimental	glioma study 16 (secondary glioblastoma)
	Secondary glioma tissues obtained from the operating room. Tumors were diagnosed and graded according to the current WHO classification (grade IV).
Control	normal brain tissue
	Normal brain tissue sample from healthy donors.

Relative Expression (log2-ratio):3.8703127
Number of Samples:8 / 2

Experimental	glioma study 16 (astrocytoma)
	Primary astrocytoma tissues obtained from the operating room. Tumors were diagnosed and graded according to the current WHO classification (grade III-IV).
Control	normal brain tissue
	Normal brain tissue sample from healthy donors.

Relative Expression (log2-ratio):3.8465033
Number of Samples:3 / 3

Experimental	memory T-cell activation study 1
	Memory (CD45RA-) CD4+ T-cells isolated from peripheral blood of healthy female donors were activated with anti-CD3/CD28 beads for 24hrs.
Control	untreated memory CD4 T-cell sample
	Memory (CD45RA-) CD4+ T-cells were isolated from peripheral blood of healthy female donors and incubated in X-VIVO 20 medium for 24 hours, before harvest for RNA isolation.

Relative Expression (log2-ratio):3.6765041
Number of Samples:7 / 2

Experimental	glioma study 16 (oligodendroglioma)
	Primary oligodendroglioma tissues obtained from the operating room. Tumors were diagnosed and graded according to the current WHO classification (grade OGII-III).
Control	normal brain tissue
	Normal brain tissue sample from healthy donors.